Percentage of CD19+ Cells in Peripheral Blood Lymphocytes After Rituximab-Based Desensitization as a Predictor of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation

Autor: Hirose, T., Iwami, D., Hotta, K., Sasaki, H., Higuchi, H., Shinohara, N.
Zdroj: In Transplantation Proceedings June 2019 51(5):1382-1386
Databáze: ScienceDirect